MAF Flight Delivers 550kg of Vaccines to Combat Ebola in Democratic Republic of the Congo
19 déc. 2018 11h44 HE
|
MAF Canada
NYANKUNDE, Democratic Republic of the Congo, Dec. 19, 2018 (GLOBE NEWSWIRE) -- On December 18, 2018, an MAF flight delivered 550kg of vaccines to Beni, the epicentre of the current Ebola virus...
GeoVax Presenting at Upcoming Scientific Conferences
07 nov. 2018 09h00 HE
|
GeoVax, Inc.
Plug & Play Platform Continues to be Recognized for Distinct Benefits ATLANTA, GA, Nov. 07, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology...
Aphios Is Developing Pathogen Inactivation Technology For Human Plasma Units
26 sept. 2018 08h00 HE
|
Aphios
WOBURN, Mass., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Aphios Corporation today announced that it has been awarded a Phase I Small Business Innovative Research (SBIR) grant from the National Heart Lung...
GeoVax Strengthens Scientific Staff and Expertise
29 août 2018 09h00 HE
|
GeoVax, Inc.
ATLANTA, GA, Aug. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today announced the strengthening of its...
GeoVax to Present at the 2018 ASM Microbe Conference
30 mai 2018 09h00 HE
|
GeoVax, Inc.
ATLANTA, GA. , May 30, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), winner of the 2018 “Best Biotech” Vaccine Industry Excellence Award at the World Vaccine Congress, announced today...
RedHill Biopharma Announces New U.S. Patent for its Experimental Ebola Therapy
29 mai 2018 08h00 HE
|
RedHill Biopharma Ltd.
TEL-AVIV, Israel and RALEIGH, N.C., May 29, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical...
GeoVax to Conduct Partnering Meetings During BIO International Convention June 4-7
22 mai 2018 09h00 HE
|
GeoVax, Inc.
CEO Robert McNally to Speak as part of BIO’s One Health Day Program ATLANTA, GA., May 22, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human...
GeoVax to Present its MVA Vector Platform Technology at Vaccinology Conference
19 avr. 2018 09h00 HE
|
GeoVax, Inc.
ATLANTA, GA, April 19, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that its Chief Scientific Officer, Dr. Farshad...
GeoVax Recognized as “Best Biotech” at Vaccine Industry Excellence Awards during World Vaccine Congress
05 avr. 2018 09h00 HE
|
GeoVax, Inc.
ATLANTA, GA, April 05, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, is honored to announce that it won “Best Biotech” at the World...
SwRI turbocharges drug discovery using mobile phone technology
16 mai 2017 16h24 HE
|
Southwest Research Institute
San Antonio, May 16, 2017 (GLOBE NEWSWIRE) -- For immediate release Southwest Research Institute® (SwRI®) has tapped has tapped into mobile communications technology to turbocharge its custom...